Bob Hopkins
Stock Analyst at B of A Securities
(1.17)
# 3,285
Out of 4,804 analysts
55
Total ratings
60%
Success rate
-17.2%
Average return
Main Sectors:
Stocks Rated by Bob Hopkins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | $220 → $255 | $141.41 | +80.33% | 5 | Nov 20, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $90 → $100 | $90.64 | +10.33% | 5 | Oct 22, 2024 | |
| SGHT Sight Sciences | Downgrades: Underperform | $10 → $4.5 | $2.09 | +115.31% | 4 | Sep 13, 2023 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $48 | $48.82 | -1.68% | 1 | Oct 11, 2021 | |
| ABT Abbott Laboratories | Maintains: Buy | $133 | $123.95 | +7.30% | 2 | Aug 31, 2021 | |
| LUNG Pulmonx | Upgrades: Buy | $72 | $5.72 | +1,158.74% | 2 | Mar 10, 2021 | |
| ISRG Intuitive Surgical | Downgrades: Neutral | $242 → $253 | $457.63 | -44.64% | 7 | Sep 8, 2020 | |
| PEN Penumbra | Downgrades: Neutral | n/a | $255.82 | - | 2 | Sep 8, 2020 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $85 → $95 | $16.37 | +480.33% | 5 | May 22, 2020 | |
| JNJ Johnson & Johnson | Upgrades: Buy | n/a | $150.00 | - | 2 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $37 → $30 | $88.48 | -66.09% | 2 | Oct 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $105 | $81.88 | +28.24% | 7 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $83 | $27.97 | +196.75% | 6 | May 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $260 | $200.83 | +29.46% | 4 | Jan 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $68.64 | - | 1 | Nov 10, 2017 |
Inspire Medical Systems
Nov 20, 2024
Upgrades: Buy
Price Target: $220 → $255
Current: $141.41
Upside: +80.33%
Boston Scientific
Oct 22, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $90.64
Upside: +10.33%
Sight Sciences
Sep 13, 2023
Downgrades: Underperform
Price Target: $10 → $4.5
Current: $2.09
Upside: +115.31%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $48
Current: $48.82
Upside: -1.68%
Abbott Laboratories
Aug 31, 2021
Maintains: Buy
Price Target: $133
Current: $123.95
Upside: +7.30%
Pulmonx
Mar 10, 2021
Upgrades: Buy
Price Target: $72
Current: $5.72
Upside: +1,158.74%
Intuitive Surgical
Sep 8, 2020
Downgrades: Neutral
Price Target: $242 → $253
Current: $457.63
Upside: -44.64%
Penumbra
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $255.82
Upside: -
Tandem Diabetes Care
May 22, 2020
Maintains: Neutral
Price Target: $85 → $95
Current: $16.37
Upside: +480.33%
Johnson & Johnson
Apr 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $150.00
Upside: -
Oct 31, 2019
Maintains: Underperform
Price Target: $37 → $30
Current: $88.48
Upside: -66.09%
Aug 22, 2018
Maintains: Buy
Price Target: $98 → $105
Current: $81.88
Upside: +28.24%
May 22, 2018
Maintains: Buy
Price Target: $73 → $83
Current: $27.97
Upside: +196.75%
Jan 19, 2018
Reinstates: Buy
Price Target: $260
Current: $200.83
Upside: +29.46%
Nov 10, 2017
Upgrades: Neutral
Price Target: n/a
Current: $68.64
Upside: -